$1.28
-0.12-8.57%
Regentis Biomaterials Ltd
RGNTAMEX
Regentis Biomaterials (RGNT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| FY | Feb 24, 2026 | $-24.16 | $-0.68 | -3452.9 % |
Quarterly Revenue (Billions)
| Metric | H1 '26 | FY '25 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | — | $-0.68 |
| Actual | $-0.44 | $-24.16 |
| Surprise | — | -3452.9% |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
| Metric | FY '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-0.68 |
| Revenue | |
| Consensus | — |
